FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 295:1449-1454 December 23, 1976 Number 26 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To delineate the normal function of purine nucleoside phosphorylase and to understand the pathogenesis of the immune dysfunction associated with deficiency of this enzyme, we studied purine metabolism in a patient deficient in purine nucleoside phosphorylase, her erythrocytes and cultured fibroblasts. She exhibited severe hypouricemia and hypouricosuria but excreted excessive amounts of purines in her urine, the major components of which were inosine and guanosine. Her urine also contained deoxyinosine, deoxyguanosine and uric acid 9-N riboside. The patient's erythrocytes but not her cultured fibroblasts contained increased concentrations of phosphoribosylpyrophosphate and inosine. The metabolic abnormalities resembled those in the erythrocytes of patients with the Lesch-Nyhan syndrome. Purine nucleoside phosphorylase is a necessary component of the major, if not the sole, pathway for the conversion of purine nucleosides and nucleotides to uric acid. The increased intracellular concentrations of inosine may, by inhibiting adenosine deaminase, be related to the immunologic dysfunction.

This article has been cited by other articles:

• Gandhi, V., Kilpatrick, J. M., Plunkett, W., Ayres, M., Harman, L., Du, M., Bantia, S., Davisson, J., Wierda, W. G., Faderl, S., Kantarjian, H., Thomas, D. (2005). A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood 106: 4253-4260 [Abstract] [Full Text]  
• Arpaia, E., Benveniste, P., Di Cristofano, A., Gu, Y., Dalal, I., Kelly, S., Hershfield, M., Pandolfi, P. P., Roifman, C. M., Cohen, A. (2000). Mitochondrial Basis for Immune Deficiency: Evidence from Purine Nucleoside Phosphorylase-deficient Mice. J. Exp. Med. 191: 2197-2208 [Abstract] [Full Text]  
• Snyder, F. F., Jenuth, J. P., Mably, E. R., Mangat, R. K. (1997). Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse. Proc. Natl. Acad. Sci. USA 94: 2522-2527 [Abstract] [Full Text]  
• Edwards, N., Magilavy, D., Cassidy, J., Fox, I. (1978). Lymphocyte ecto-5'-nucleotidase deficiency in agammaglobulinemia. Science 201: 628-630 [Abstract]  
• Fox, I., Andres, C., Gelfand, E., Biggar, D (1977). Purine nucleoside phosphorylase deficiency: altered kinetic properties of a mutant enzyme. Science 197: 1084-1086 [Abstract]